Drug
Ritlecitinib
Ritlecitinib: highest development phase Phase 2, developed by Pfizer. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ritlecitinib NCT07228390 | Phase 2 | Hidradenitis Suppurativa |
| ritlecitinib NCT05040295 | Phase 1 | Healthy Participants |
Latest
Follow Ritlecitinib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.